Japan News
-
Sommetrics completes study of new sleep apnea treatment in ethnic Japanese subjects
Japan | News | 0 Comment | 26 Jun, 2019
Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA) has announced the completion of clinical study SOM-014. This trial evaluated t...Read more
-
Daiichi Sankyo, GE Healthcare sign marketing deal for four imaging agents
Japan | News | 0 Comment | 26 Jun, 2019
Daiichi Sankyo Company, Limited and GE Healthcare have agreed that, Daiichi Sankyo will return the exclusive development and marketing rights in Japan for four approved diagnostic imaging a...Read more
-
Gilead, Carna Biosciences announce R&D collaboration
Japan | News | 0 Comment | 25 Jun, 2019
US headquartered Gilead Sciences and Japan based Carna Biosciences has announced that the companies have entered into a research and development collaboration to develop and commercial...Read more
-
Shionogi collaborates with Eddingpharm for TPO receptor agonist
Japan | News | 0 Comment | 24 Jun, 2019
Japanese research-driven pharmaceutical company Shionogi & Co., Ltd., on 24 June 2019, announces that the Company has concluded an agreement with China based Eddingpharm to license...Read more
-
Ricoh announces strategic business partnership with Elixirgen Scientific
Japan | News | 0 Comment | 21 Jun, 2019
Ricoh Company, Ltd., (Tokyo, Japan) has announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc., (Baltimore, Maryland, USA), to develop innovative bio...Read more
-
Toray launches TORAYMYXIN in EU market
Japan | News | 0 Comment | 21 Jun, 2019
Japan headquartered Toray has announced that a small size of TORAYMYXINTM (PMX-05R) had obtained EC certificate and is launched in the EU market on this month. TORAYMYXINTM is indicated fo...Read more
-
Japan | News | 0 Comment | 21 Jun, 2019
Myriad Genetic Laboratories, a wholly-owned subsidiary of Myriad Genetics has announced the Japanese Ministry of Health, Labour, and Welfare has granted a second manufacturing an...Read more
-
Eisai discovers new anti-cancer compound
Japan | News | 0 Comment | 21 Jun, 2019
Eisai, a leading global research and development-based pharmaceutical company headquartered in Japan has announced that a joint research group including scientists from Eisai and Profe...Read more
-
Ricoh announces strategic business partnership with Elixirgen Scientific
Japan | News | 0 Comment | 20 Jun, 2019
Ricoh Company has announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc. to develop innovative biomedical products and services that support drug dis...Read more
-
Japan the first to approve Roche’s personalised medicine Rozlytrek
Japan | News | 0 Comment | 19 Jun, 2019
Roche has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrectinib) for the treatment of adult and paediatric patients with neurot...Read more
-
Daiichi Sankyo’s VANFLYTA® receives approval for the treatment of Relapsed/Refractory FLT3-ITD AML
Japan | News | 0 Comment | 18 Jun, 2019
Daiichi Sankyo Company has announced that the Ministry of Health, Labor and Welfare (MHLW) of Japan has approved VANFLYTA® (quizartinib), an oral FLT3 inhibitor, for the treatment of ad...Read more
-
Catalys Pacific to advance early-stage life sciences innovation
Japan | News | 0 Comment | 18 Jun, 2019
Catalys Pacific, a new venture capital firm in Japan built by a global team seasoned in life sciences investing, on 17 June 2019, Tokyo, announced the launch of its first fund. Le...Read more
-
Teijin Pharma starts exclusive sale of TMS device in Japan
Japan | News | 0 Comment | 17 Jun, 2019
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has started exclusive sales of NeuroStar® Transcranial Magnetic ...Read more
-
Terumo secures exclusive global rights to Orchestra BioMed's SEB
Japan | News | 0 Comment | 14 Jun, 2019
Japan headquartered Terumo Corporation, a leading global medical device manufacturer has announced that it has secured exclusive global development and commercialization rights to Virtue&re...Read more
-
BiomX licenses novel targets for phage therapy program
Japan | News | 0 Comment | 13 Jun, 2019
BiomX Ltd., a microbiome company developing both natural and engineered phage therapies has announced it has licensed a new set of bacterial targets from JSR Corporation, Japan for the deve...Read more
-
Acucela gets EMA approval for Emixustat to treat Stargardt disease
Japan | News | 0 Comment | 11 Jun, 2019
Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), recently announced that th...Read more
-
Sosei Heptares to receive new $3 million milestone payment from Pfizer
Japan | News | 0 Comment | 10 Jun, 2019
Sosei Group Corporation and its strategic alliance partner Pfizer announce that a new clinical candidate from their multi-target drug discovery collaboration was nominated to advance into c...Read more
-
Hamamatsu Photonics develops novel 3D fluorescence scanner
Japan | News | 0 Comment | 11 Jun, 2019
Hamamatsu Photonics K.K. has developed a novel 3D fluorescence scanning method called “Zyncscan™” that performs x-z plane scans using a light-sheet for cell-based fluoresc...Read more
